Results 251 to 260 of about 2,811,792 (409)

Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?

open access: green, 2005
Massimo Volpe   +4 more
openalex   +2 more sources

Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi   +9 more
wiley   +1 more source

The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats

open access: green, 2006
Salah Eldin Kassab   +6 more
openalex   +2 more sources

Angiotensin II Type 2 Receptor Deletion Enhances Vascular Senescence by Methyl Methanesulfonate Sensitive 2 Inhibition [PDF]

open access: bronze, 2008
Li‐Juan Min   +8 more
openalex   +1 more source

Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers

open access: yesCancer, 2016
Z. Morris   +12 more
semanticscholar   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh   +18 more
wiley   +1 more source

The effect of angiotensin receptor blockers on peripheral artery disease progression: A retrospective cohort study in Jordan. [PDF]

open access: yesPLoS One
Kasasbeh MZ   +5 more
europepmc   +1 more source

Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

open access: yesCirculation, 2015
M. Packer   +51 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy